The Dyspnea market growth is driven by factors like increase in the prevalence of Dyspnea, investments in research and development, entry of emerging therapies during the study period 2020-2032. The ...

EXETER, N.H., May 20, 2025 /PRNewswire/ -- Vapotherm, Inc., the global leader in mask-free noninvasive respiratory support, is proud to announce the publication of a new clinical study, Effect of ...

The APN possesses the advanced clinical knowledge and skills to be able to synthesize the assessment information and create a comprehensive plan -- including pharmacologic and nonpharmacologic ...

Based on responses from 178 providers, the researchers found that most providers (77 percent) agree that dyspnea relief is an important goal when treating patients with cardiopulmonary conditions. The ...

ORLANDO, FL — The oral vasopressin-2 receptor antagonist tolvaptan (Samsca, Otsuka American Pharmaceutical) indeed promotes significant loss of fluid volume in patients with acute decompensated heart ...

Biochemical correlates of fatigue in patients at a comprehensive cancer center. Background: Dyspnea is an uncomfortable sensation of breathing that is common in hospice patients regardless of terminal ...

Population-based prospective cohort study of psychosocial factors and survival of young Australian women with breast cancer No significant financial relationships to disclose. This is an ASCO Meeting ...

The Nature Index 2026 Research Leaders reveal the leading institutions and countries/territories in the natural sciences, health sciences, applied sciences and social sciences, according to their ...

Please provide your email address to receive an email when new articles are posted on . Patients with recently diagnosed HF had greater early dyspnea relief and improved survival after hospital ...

Please provide your email address to receive an email when new articles are posted on . AMSTERDAM — Omecamtiv mecarbil did not meet the primary endpoint of reducing dyspnea in patients with acute HF ...

(HealthDay News) — The majority of hospitalists believe that routinely assessing dyspnea severity would enhance their clinical decision making and positively affect patient care, according to a study ...